Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 4
2022 5
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
STAT3-EMT axis in tumors: Modulation of cancer metastasis, stemness and therapy response.
Sadrkhanloo M, Entezari M, Orouei S, Ghollasi M, Fathi N, Rezaei S, Hejazi ES, Kakavand A, Saebfar H, Hashemi M, Goharrizi MASB, Salimimoghadam S, Rashidi M, Taheriazam A, Samarghandian S. Sadrkhanloo M, et al. Among authors: goharrizi masb. Pharmacol Res. 2022 Aug;182:106311. doi: 10.1016/j.phrs.2022.106311. Epub 2022 Jun 15. Pharmacol Res. 2022. PMID: 35716914 Review.
Biological impact and therapeutic perspective of targeting PI3K/Akt signaling in hepatocellular carcinoma: Promises and Challenges.
Paskeh MDA, Ghadyani F, Hashemi M, Abbaspour A, Zabolian A, Javanshir S, Razzazan M, Mirzaei S, Entezari M, Goharrizi MASB, Salimimoghadam S, Aref AR, Kalbasi A, Rajabi R, Rashidi M, Taheriazam A, Sethi G. Paskeh MDA, et al. Among authors: goharrizi masb. Pharmacol Res. 2023 Jan;187:106553. doi: 10.1016/j.phrs.2022.106553. Epub 2022 Nov 15. Pharmacol Res. 2023. PMID: 36400343 Free article. Review.
Biological landscape and nanostructural view in development and reversal of oxaliplatin resistance in colorectal cancer.
Hashemi M, Esbati N, Rashidi M, Gholami S, Raesi R, Bidoki SS, Goharrizi MASB, Motlagh YSM, Khorrami R, Tavakolpournegari A, Nabavi N, Zou R, Mohammadnahal L, Entezari M, Taheriazam A, Hushmandi K. Hashemi M, et al. Among authors: goharrizi masb. Transl Oncol. 2024 Feb;40:101846. doi: 10.1016/j.tranon.2023.101846. Epub 2023 Dec 1. Transl Oncol. 2024. PMID: 38042134 Free PMC article. Review.
The role of microRNA-338-3p in cancer: growth, invasion, chemoresistance, and mediators.
Mirzaei S, Zarrabi A, Asnaf SE, Hashemi F, Zabolian A, Hushmandi K, Raei M, Goharrizi MASB, Makvandi P, Samarghandian S, Najafi M, Ashrafizadeh M, Aref AR, Hamblin MR. Mirzaei S, et al. Among authors: goharrizi masb. Life Sci. 2021 Mar 1;268:119005. doi: 10.1016/j.lfs.2020.119005. Epub 2021 Jan 6. Life Sci. 2021. PMID: 33421526 Review.
Long non-coding RNAs and exosomal lncRNAs: Potential functions in lung cancer progression, drug resistance and tumor microenvironment remodeling.
Entezari M, Ghanbarirad M, Taheriazam A, Sadrkhanloo M, Zabolian A, Goharrizi MASB, Hushmandi K, Aref AR, Ashrafizadeh M, Zarrabi A, Nabavi N, Rabiee N, Hashemi M, Samarghandian S. Entezari M, et al. Among authors: goharrizi masb. Biomed Pharmacother. 2022 Jun;150:112963. doi: 10.1016/j.biopha.2022.112963. Epub 2022 Apr 22. Biomed Pharmacother. 2022. PMID: 35468579 Free article. Review.
Biological functions and molecular interactions of Wnt/β-catenin in breast cancer: Revisiting signaling networks.
Hashemi M, Hasani S, Hajimazdarany S, Ghadyani F, Olyaee Y, Khodadadi M, Ziyarani MF, Dehghanpour A, Salehi H, Kakavand A, Goharrizi MASB, Aref AR, Salimimoghadam S, Akbari ME, Taheriazam A, Hushmandi K, Entezari M. Hashemi M, et al. Among authors: goharrizi masb. Int J Biol Macromol. 2023 Mar 31;232:123377. doi: 10.1016/j.ijbiomac.2023.123377. Epub 2023 Jan 23. Int J Biol Macromol. 2023. PMID: 36702226 Review.
14 results